Development and optimization of the manufacturing technology for "Antioxim" capsules

This scientific article investigates the biopharmaceutical properties of a newly recommended three-component capsule formulation, "Antioxim," using both in vitro and in vivo methodologies. The experimental studies evaluated the dry extract of "Antioxim" obtained using 40% and 70% ethyl alcohol. The in vitro results demonstrated that the three-component dry extract effectively prevents the autooxidation of adrenaline, confirming its strong antioxidant activity. Additionally, in vivo evaluations of acute toxicity showed that the "Antioxim" dry extract exhibits no toxic clinical signs and can be classified as a non-toxic substance. Overall, these findings highlight the therapeutic potential and safety profile of "Antioxim" capsules for further biomedical applications.

Hali tarjima qilinmagan